Latest Insider Transactions at Bluebird Bio, Inc. (BLUE)
This section provides a real-time view of insider transactions for Bluebird Bio, Inc. (BLUE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of bluebird bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of bluebird bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2021
|
William D Baird Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
693
-1.91%
|
$19,404
$28.16 P/Share
|
|
Feb 16
2021
|
Nick Leschly |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+14.67%
|
-
|
|
Feb 16
2021
|
Jason Cole Chief Strategy & Financial Off |
BUY
Grant, award, or other acquisition
|
Direct |
15,915
+13.53%
|
-
|
|
Feb 16
2021
|
David Davidson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,271
+11.11%
|
-
|
|
Feb 16
2021
|
Andrew Obenshain President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,065
+16.32%
|
-
|
|
Feb 16
2021
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,662
+12.96%
|
-
|
|
Feb 16
2021
|
Katy Burnett Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,427
+31.08%
|
-
|
|
Feb 16
2021
|
William D Baird Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,641
+16.21%
|
-
|
|
Feb 12
2021
|
William D Baird Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,216
-5.33%
|
$54,720
$45.52 P/Share
|
|
Feb 02
2021
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.18%
|
$2,655
$45.93 P/Share
|
|
Feb 02
2021
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.12%
|
$1,710
$45.93 P/Share
|
|
Feb 02
2021
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
594
-0.68%
|
$26,730
$45.93 P/Share
|
|
Feb 02
2021
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
63
-0.17%
|
$2,835
$45.93 P/Share
|
|
Feb 02
2021
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
34
-0.14%
|
$1,530
$45.93 P/Share
|
|
Jan 07
2021
|
Ramy Ibrahim Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,250
+50.0%
|
-
|
|
Jan 06
2021
|
William D Baird Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
949
-2.02%
|
$42,705
$45.11 P/Share
|
|
Jan 06
2021
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,754
-3.93%
|
$123,930
$45.11 P/Share
|
|
Jan 06
2021
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
1,287
-2.98%
|
$57,915
$45.11 P/Share
|
|
Jan 06
2021
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
2,358
-3.41%
|
$106,110
$45.11 P/Share
|
|
Jan 06
2021
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,167
-4.09%
|
$142,515
$45.11 P/Share
|
|
Jan 06
2021
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,814
-3.43%
|
$81,630
$45.11 P/Share
|
|
Jan 06
2021
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
10,095
-5.32%
|
$454,275
$45.11 P/Share
|
|
Jan 05
2021
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45
-0.13%
|
$1,980
$44.95 P/Share
|
|
Jan 05
2021
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
42
-0.19%
|
$1,848
$44.95 P/Share
|
|
Jan 05
2021
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
43
-0.12%
|
$1,892
$44.95 P/Share
|
|
Jan 05
2021
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
48
-0.12%
|
$2,112
$44.95 P/Share
|
|
Jan 05
2021
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
40
-0.15%
|
$1,760
$44.95 P/Share
|
|
Jan 05
2021
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
333
-0.34%
|
$14,652
$44.95 P/Share
|
|
Dec 03
2020
|
Katy Burnett Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
123
-7.77%
|
$5,658
$46.09 P/Share
|
|
Dec 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.23%
|
$20,424
$46.34 P/Share
|
|
Dec 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.08%
|
$2,944
$46.34 P/Share
|
|
Dec 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.08%
|
$2,714
$46.34 P/Share
|
|
Dec 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.05%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.09%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.07%
|
$1,656
$46.34 P/Share
|
|
Nov 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.15%
|
$23,532
$53.59 P/Share
|
|
Nov 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
63
-0.05%
|
$3,339
$53.59 P/Share
|
|
Nov 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.05%
|
$3,127
$53.59 P/Share
|
|
Nov 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
37
-0.03%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
37
-0.06%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
35
-0.04%
|
$1,855
$53.59 P/Share
|
|
Oct 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
60
-0.17%
|
$3,120
$52.77 P/Share
|
|
Oct 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
450
-0.45%
|
$23,400
$52.77 P/Share
|
|
Oct 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.13%
|
$1,872
$52.77 P/Share
|
|
Oct 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.17%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.11%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.16%
|
$3,328
$52.77 P/Share
|